FDA Rule Aims To Improve Reporting For Drug Trials
The U.S. Food and Drug Administration has announced new rules that it said would increase the quality of safety information it receives during clinical trials of investigational drugs and biologics....To view the full article, register now.
Already a subscriber? Click here to view full article